Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1 1

Status

Completed 4Terminated 2Recruiting 2Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Breast 1

Conditions

Solid Tumor 1Osteoporosis 1Lymphatic Metastasis 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Technetium × Clear all
NCT06443710 2025-07-15

Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers

Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.

Phase 1 Completed
24 enrolled
Other solid neoplasm

Solid Tumor

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed
409 enrolled
Thoracic

Lung Neoplasms, Lymphatic Metastasis

NCT02304757 2021-11-17

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
142 enrolled 7 charts

Osteoporosis

NCT02279108 2018-04-09

FLUOTECH

Centre Hospitalier Universitaire de Saint Etienne

Phase 3 Completed
99 enrolled 15 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡